Find the right fit for you - faster
Get tailored insights about working at Intercytex in one quick step.
Intercytex Snapshot
Intercytex would like to see a swift end to the toupee business. The company is developing cell-based treatments for skin and hair regeneration. Its ICX-TRC product candidate is injected just beneath the scalp to encourage new hair follicles to form. If the candidate wins approval in the US, Intercytex has lined up Bosley Medical Institute, a firm that manages hair transplant clinics across the US, to help distribute its regeneration product. Another product candidate, ICX-PRO, could treat diabetic ulcers and other chronic dermal wounds. Its ICX-RHY launched in 2007, under the name Valvelta, as a cosmetic facial rejuvenation product injected transdermally to smoothe out wrinkles.
